126 related articles for article (PubMed ID: 8148799)
1. Long circulating emulsion carrier systems for highly lipophilic drugs.
Takino T; Konishi K; Takakura Y; Hashida M
Biol Pharm Bull; 1994 Jan; 17(1):121-5. PubMed ID: 8148799
[TBL] [Abstract][Full Text] [Related]
2. Controlled biodistribution of highly lipophilic drugs with various parenteral formulations.
Takino T; Nakajima C; Takakura Y; Sezaki H; Hashida M
J Drug Target; 1993; 1(2):117-24. PubMed ID: 8069549
[TBL] [Abstract][Full Text] [Related]
3. Effects of cholesterol and cholesteryl oleate on lipolysis and liver uptake of triglyceride/phosphatidylcholine emulsions in rats.
Handa T; Eguchi Y; Miyajima K
Pharm Res; 1994 Sep; 11(9):1283-7. PubMed ID: 7816757
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice.
Ishida E; Managit C; Kawakami S; Nishikawa M; Yamashita F; Hashida M
Pharm Res; 2004 Jun; 21(6):932-9. PubMed ID: 15212156
[TBL] [Abstract][Full Text] [Related]
5. Control of plasma cholesterol-lowering action of probucol with various lipid carrier systems.
Takino T; Koreeda N; Nomura T; Sakaeda T; Yamashita F; Takakura Y; Hashida M
Biol Pharm Bull; 1998 May; 21(5):492-7. PubMed ID: 9635506
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution characteristics of mannosylated and fucosylated O/W emulsions in mice.
Yeeprae W; Kawakami S; Higuchi Y; Yamashita F; Hashida M
J Drug Target; 2005; 13(8-9):479-87. PubMed ID: 16332573
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of liver metastasis by all-trans retinoic acid incorporated into O/W emulsions in mice.
Chansri N; Kawakami S; Yamashita F; Hashida M
Int J Pharm; 2006 Sep; 321(1-2):42-9. PubMed ID: 16790329
[TBL] [Abstract][Full Text] [Related]
8. The effects of emulsifying agents on disposition of lipid-soluble drugs included in fat emulsion.
Suzuki Y; Masumitsu Y; Okudaira K; Hayashi M
Drug Metab Pharmacokinet; 2004 Feb; 19(1):62-7. PubMed ID: 15499171
[TBL] [Abstract][Full Text] [Related]
9. The interaction of milk sphingomyelin and proteins on stability and microstructure of dairy emulsions.
Ahn N; Park JH; Chai C; Imm JY
J Dairy Sci; 2022 May; 105(5):3832-3845. PubMed ID: 35282910
[TBL] [Abstract][Full Text] [Related]
10. Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs.
Liu F; Liu D
Pharm Res; 1995 Jul; 12(7):1060-4. PubMed ID: 7494803
[TBL] [Abstract][Full Text] [Related]
11. Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system.
Chung H; Kim TW; Kwon M; Kwon IC; Jeong SY
J Control Release; 2001 Apr; 71(3):339-50. PubMed ID: 11295226
[TBL] [Abstract][Full Text] [Related]
12. Effect of acyl chains of phosphatidylcholines on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with phosphatidylcholines and soybean oil in rats.
Ueda K; Fujimoto M; Noto H; Sakaeda T; Iwakawa S
J Pharm Pharmacol; 2004 Jul; 56(7):855-9. PubMed ID: 15233863
[TBL] [Abstract][Full Text] [Related]
13. Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsions.
Sakaeda T; Hirano K
J Drug Target; 1998; 6(4):273-84. PubMed ID: 9894695
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical properties of structured phosphatidylcholine in drug carrier lipid emulsions for drug delivery systems.
Kawaguchi E; Shimokawa K; Ishii F
Colloids Surf B Biointerfaces; 2008 Mar; 62(1):130-5. PubMed ID: 17988839
[TBL] [Abstract][Full Text] [Related]
15. Hepatic uptake of lipid-soluble drugs from fat emulsion.
Umezawa K; Karino A; Hayashi M; Tahara K; Kimura A; Awazu S
J Pharmacobiodyn; 1991 Oct; 14(10):591-8. PubMed ID: 1818101
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of highly lipophilic antitumor agent palmitoyl rhizoxin incorporated in lipid emulsions in rats.
Kurihara A; Shibayama Y; Mizota A; Yasuno A; Ikeda M; Hisaoka M
Biol Pharm Bull; 1996 Feb; 19(2):252-8. PubMed ID: 8850317
[TBL] [Abstract][Full Text] [Related]
17. Polysaccharide-coated oil droplets in oil-in-water emulsions as targetable carriers for lipophilic drugs.
Iwamoto K; Kato T; Kawahara M; Koyama N; Watanabe S; Miyake Y; Sunamoto J
J Pharm Sci; 1991 Mar; 80(3):219-24. PubMed ID: 2051336
[TBL] [Abstract][Full Text] [Related]
18. Effects of sphingomyelin and phosphatidylcholine acyl chains on the clearance of triacylglycerol-rich lipoproteins from plasma. Studies with lipid emulsions in rats.
Redgrave TG; Rakic V; Mortimer BC; Mamo JC
Biochim Biophys Acta; 1992 Jun; 1126(1):65-72. PubMed ID: 1606176
[TBL] [Abstract][Full Text] [Related]
19. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease.
Maranhão RC; Feres MC; Martins MT; Mesquita CH; Toffoletto O; Vinagre CG; Gianinni SD; Pileggi F
Atherosclerosis; 1996 Sep; 126(1):15-25. PubMed ID: 8879430
[TBL] [Abstract][Full Text] [Related]
20. A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting.
Seki J; Sonoke S; Saheki A; Fukui H; Sasaki H; Mayumi T
Int J Pharm; 2004 Apr; 273(1-2):75-83. PubMed ID: 15010132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
